

Please try another search
(Reuters) - The United States had administered 422,070,099 doses of COVID-19 vaccines in the country as of Sunday morning, the U.S. Centers for Disease Control and Prevention said.
Those figures were up from the 420,657,683 vaccine doses the CDC said had gone into arms by Saturday.
The agency said 221,520,153 people had received at least one dose, while 192,453,500 people were fully vaccinated as of 6 a.m. EDT on Sunday.
The CDC tally includes two-dose vaccines from Moderna (NASDAQ:MRNA) Inc and Pfizer (NYSE:PFE) Inc/BioNTech, as well as Johnson & Johnson (NYSE:JNJ)'s one-shot vaccine.
About 18.6 million people have received a booster dose of either Pfizer, Moderna or Johnson & Johnson's COVID-19 vaccine. Booster doses from Moderna and Johnson & Johnson were authorized by the U.S. health regulator on Oct. 20.
By Jorge Otaola BUENOS AIRES (Reuters) -Argentina's economy minister Martin Guzman, the architect of a recent major debt deal with the International Monetary Fund (IMF), resigned...
SAO PAULO (Reuters) - Former President Luiz Inacio Lula da Silva, who is leading in the polls for Brazil's October presidential election, said on Saturday he will not tolerate...
WARSAW (Reuters) - Polish banks will be taxed more if they don't offer clients higher interest on their deposits, the leader of Poland's ruling party said on Saturday,...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.